Autosomal recessive nonsyndromic deafness 23 is a genetic cause of hearing loss without other health problems. People with Autosomal recessive nonsyndromic deafness 23 typically have sensorineural hearing loss that may be present at birth or noticed in early childhood. It is lifelong, and severity can range from mild to profound. Many do well with hearing aids or cochlear implants, plus speech and language support. The outlook is generally good, and life expectancy is typical, but early evaluation helps children develop communication skills.
Overview
Autosomal recessive nonsyndromic deafness 23Symptoms
Autosomal recessive nonsyndromic deafness 23 causes permanent inner-ear hearing loss without other features. Early signs of Autosomal recessive nonsyndromic deafness 23 appear at birth or early childhood. Many don’t startle to loud noises, miss speech sounds, or develop speech late.
Outlook and prognosis
Many living with autosomal recessive nonsyndromic deafness 23 have stable, congenital hearing loss that doesn’t affect other body systems. Early diagnosis, hearing technology, and language access support communication, education, and work. Lifelong follow-up helps adjust devices and address changing needs.
Causes and risk factors
Autosomal recessive nonsyndromic deafness 23 results from inheriting two faulty copies of a hearing gene; parents are symptom-free carriers. Risk rises with family history, consanguinity. Noise or ototoxic drugs can worsen hearing but don’t cause it; onset is prenatal.
Genetic influences
Genetics are central in Autosomal recessive nonsyndromic deafness 23. It’s caused by variants in both copies of a specific gene, usually inherited from carrier parents. Different variants can influence age of onset, severity, and response to options like cochlear implants.
Diagnosis
Diagnosis of Autosomal recessive nonsyndromic deafness 23 starts with newborn or childhood hearing tests showing sensorineural hearing loss without other findings. Genetic diagnosis of Autosomal recessive nonsyndromic deafness 23 is confirmed by multigene panel testing; imaging can assess inner‑ear structure.
Treatment and drugs
Autosomal recessive nonsyndromic deafness 23 care centers on improving hearing and communication. Options may include hearing aids, cochlear implants, assistive listening devices, and tailored speech-language therapy, plus genetic counseling for family planning. Early support at school and work helps daily life.
Symptoms
Autosomal recessive nonsyndromic deafness 23 is a genetic form of hearing loss that typically shows up from birth or very early infancy. Early on, this might look like not startling to loud sounds or not turning toward a familiar voice. Parents often notice the early features of Autosomal recessive nonsyndromic deafness 23 during feeding, play, or bedtime when sound doesn’t draw attention as expected. Hearing differences are usually present in both ears and occur without vision, balance, or other health problems.
Babies may not startle to sudden noises or turn toward voices. Many do not pass the newborn hearing screen in one or both ears. Parents may see calmer-than-expected reactions to loud toys or barking dogs.
Hearing differences usually involve both ears to a similar degree. This can make quiet speech or distant sounds hard to catch. Everyday noises like whispers, timers, or birdsong may go unnoticed.
The inner ear or the hearing nerve is involved rather than the outer or middle ear. Ear canals and eardrums typically look normal on exam. Fluid or infections are not the cause.
Babbling may be quieter or less varied, and first words may come later. As toddlers, many rely more on gestures than words to communicate. Early support for communication can help close gaps.
How people usually first notice Autosomal recessive nonsyndromic deafness 23?
Many families first notice something’s different when a baby doesn’t startle at loud sounds, doesn’t turn toward a parent’s voice, or isn’t babbling as expected—often picked up on newborn hearing screening before leaving the hospital. Autosomal recessive nonsyndromic deafness 23 typically shows up as hearing loss without other physical differences, so the first signs of Autosomal recessive nonsyndromic deafness 23 are usually missed sounds and delayed speech responses rather than visible traits. When a screening test is missed or inconclusive, caregivers and doctors often recognize how Autosomal recessive nonsyndromic deafness 23 is first noticed during the first months through follow-up hearing tests that confirm reduced hearing in one or both ears.
Types of Autosomal recessive nonsyndromic deafness 23
Autosomal recessive nonsyndromic deafness 23 (DFNB23) is a genetic form of hearing loss caused by changes in the PCDH15 gene. Variants of this condition mostly differ by which part of the inner ear is affected and how early and how severely hearing is reduced. Symptoms don’t always look the same for everyone. Clinicians often describe them in these categories:
Congenital severe-profound
Hearing loss is present from birth and is typically severe to profound. Most develop limited or no spoken language without early amplification or cochlear implants. Balance is usually normal.
Prelingual moderate-severe
Hearing loss starts in infancy or early childhood and is moderate to severe. Kids may respond to loud voices but struggle with soft speech, especially with background noise. Hearing aids often help, and speech usually develops with support.
Progressive childhood-onset
Hearing starts near normal and declines during childhood. Families may notice the TV creeping louder or frequent “what?” in school. Regular hearing tests track the change and guide timing of hearing devices.
Frequency-specific loss
Some have greater loss at high pitches than low ones. Conversations with women’s or children’s voices and high-pitched consonants like s, f, and t are harder to catch. Low-pitched sounds may still feel comparatively clear.
Associated vestibular features
A subset reports dizziness or unsteady walking, suggesting inner-ear balance involvement. This can show up as delayed walking or clumsiness in toddlers. Vestibular therapy helps many adapt.
Genetic variant differences
Different PCDH15 mutations can lead to milder or more severe hearing loss. Truncating variants are often linked to earlier, more severe loss, while some missense changes may be milder. These genetic differences underlie the variants of Autosomal recessive nonsyndromic deafness 23.
What genetics can tell you about symptoms
Some people with autosomal recessive nonsyndromic deafness 23 have changes in the PCDH15 gene that disrupt inner‑ear hair cell links, leading to congenital, usually severe to profound sensorineural hearing loss in both ears. Different variants can shift onset and degree, from early profound loss to milder, later childhood loss.
Causes and risk factors
Autosomal recessive nonsyndromic deafness 23 is caused by changes in both copies of the PCDH15 gene inherited from carrier parents. Carriers usually have normal hearing, but two carriers have a higher chance of having an affected child. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t). Loud noise, certain antibiotics or chemotherapy drugs, and repeated ear infections can worsen hearing but do not cause Autosomal recessive nonsyndromic deafness 23. Risk is higher with a family history or when parents are closely related by blood, and genetic counseling can explain risk factors for Autosomal recessive nonsyndromic deafness 23.
Environmental and biological risk factors
Autosomal recessive nonsyndromic deafness 23 most often begins before birth and is driven by biology present from the start. Outside of that, risk factors for autosomal recessive nonsyndromic deafness 23 are not well established in the environment or during pregnancy. Some risks are carried inside the body, others come from the world around us. Below are environmental and biological elements that are not known to raise its likelihood, and where hearing loss may come from different pathways.
There is no established environmental exposure that causes autosomal recessive nonsyndromic deafness 23. Toxic chemicals, high noise levels, or radiation can harm hearing in other ways, but they do not change the chance of this specific condition.
Infections such as rubella, cytomegalovirus, or toxoplasmosis can lead to congenital hearing loss, but they are not known to cause autosomal recessive nonsyndromic deafness 23. When hearing loss follows these infections, it arises through different pathways than this condition.
Advanced maternal or paternal age has not been shown to increase the likelihood of autosomal recessive nonsyndromic deafness 23. Age-related risks usually involve extra or missing chromosomes, a different pathway than this condition.
Conditions like diabetes or thyroid disease can affect fetal development, yet they have not been linked to a higher chance of autosomal recessive nonsyndromic deafness 23. These health factors may contribute to other types of hearing differences instead.
Genetic risk factors
In many families, the risk for this type of childhood hearing loss stays hidden until a baby fails a newborn hearing screen. Autosomal recessive nonsyndromic deafness 23 (DFNB23) happens when a child inherits two nonworking copies of a gene called PCDH15, which helps inner-ear cells sense sound. Because it often begins at birth, families may notice early symptoms of Autosomal recessive nonsyndromic deafness 23, but the underlying driver is the inherited gene change. In some cases, genetic testing can give a clearer picture of your personal risk.
PCDH15 gene changes: Variants in the PCDH15 gene disrupt connections between sound-sensing cells in the inner ear. This interferes with sound signals and leads to permanent hearing loss.
Two copies needed: A child must inherit one changed copy of PCDH15 from each parent to be affected. People with only one changed copy are carriers and usually hear normally. When both parents are carriers, each pregnancy has a 25% chance of an affected child.
Copy-number changes: Large missing or extra pieces of the PCDH15 gene (deletions or duplications) can also cause DFNB23. These may not be found by tests that only check single-letter changes. Including copy-number analysis increases the chance of finding the cause.
Founder variants: In some communities, a specific PCDH15 change is more common due to a historical founder effect. People with this ancestry may have a higher chance of being carriers. Targeted testing for known founder changes can be informative.
Parental relatedness: Parents who are related by blood are more likely to share the same rare PCDH15 change. This raises the chance a child will inherit two altered copies. Genetic counseling can explain this pattern and options.
Usher syndrome overlap: Some PCDH15 changes cause a related condition with both hearing and vision symptoms (Usher syndrome), while others cause hearing loss only. Knowing the exact variants helps tell these apart. DFNB23 does not include the eye symptoms seen in Usher syndrome.
Variant severity: Changes that stop the protein early often lead to profound hearing loss from birth. Changes that alter the protein’s shape may leave some function and result in milder loss. Still, severity can differ between and within families.
Family recurrence: Full siblings of an affected child have a 25% chance to be affected, a 50% chance to be carriers, and a 25% chance to inherit neither change. More distant relatives may also be carriers without symptoms. Testing at-risk relatives can inform future pregnancies.
Lifestyle risk factors
Lifestyle choices do not cause this condition, but they can shape communication access, preserve any residual hearing, and influence safety and device outcomes. Understanding how lifestyle affects Autosomal recessive nonsyndromic deafness 23 helps focus on choices that support hearing technology, language development, and balance. The following elements highlight practical, modifiable areas that matter day to day.
Repeated loud music or noisy hobbies can further reduce any residual hearing and worsen sound tolerance. Using hearing protection and safe-listening headphone limits helps preserve remaining function and comfort.
Nicotine and smoke can impair inner-ear blood flow and accelerate cochlear damage, risking loss of residual hearing. Avoiding tobacco and vaping also supports healing after ear procedures or cochlear implantation.
Heavy drinking worsens balance and increases fall risk, which can be critical if you have vestibular symptoms. Moderate or no alcohol supports safer mobility and clearer communication in complex listening settings.
Balance and core-strengthening exercises can reduce falls and dizziness if vestibular issues are present. Regular aerobic activity supports attention and processing that help with speechreading and device use.
Risk prevention
Autosomal recessive nonsyndromic deafness 23 is inherited, so you can’t fully prevent the condition itself, but you can lower the chance of having an affected child and help protect any remaining hearing. Prevention here focuses on family planning, early detection, and avoiding extra damage to hearing over time. Some prevention is universal, others are tailored to people with specific risks. Acting early often makes daily communication and learning easier for children and lowers stress for families.
A simple blood or saliva test can show if you and a partner carry the gene changes linked to this condition. Knowing carrier status helps estimate the chance of having a child with autosomal recessive nonsyndromic deafness 23.
A genetics professional can explain inheritance, test options, and what results mean for your family. Counseling also supports values-based decisions and connects you with resources.
In-vitro fertilization with embryo testing or prenatal diagnostic testing can reduce the chance of having a child with this condition. These choices are personal; a counselor can help you weigh benefits and limits.
Universal newborn hearing checks can flag early symptoms of autosomal recessive nonsyndromic deafness 23 when they are otherwise easy to miss. Screenings and check-ups are part of prevention too.
Transmission
Autosomal recessive nonsyndromic deafness 23 is inherited, not contagious, so it can’t be caught or spread through everyday contact, air, food, or sex. The genetic transmission of Autosomal recessive nonsyndromic deafness 23 follows an autosomal recessive pattern: a child needs two nonworking copies of the gene, one from each parent, to have the condition.
Parents who each carry one nonworking copy usually have typical hearing, but with every pregnancy there’s a 25% chance the child will have the condition, a 50% chance the child will be a carrier, and a 25% chance the child will inherit no nonworking copy. A brand‑new gene change can happen occasionally, which is why some families have no prior history, and many learn about how Autosomal recessive nonsyndromic deafness 23 is inherited only after a child is diagnosed. Carrier testing and genetic counseling can help relatives understand their chances for future pregnancies.
When to test your genes
Consider genetic testing if you or close relatives have early-onset, bilateral hearing loss without other medical features, especially if it began in childhood. Testing is also useful before family planning, during newborn evaluation after a failed hearing screen, or when hearing aids/cochlear implant decisions are being made. Results can clarify cause, guide surveillance, and inform recurrence risk.
Diagnosis
For many families, the first clues are noticed early—missing newborn hearing screens, not turning toward sounds, or delayed babbling. Autosomal recessive nonsyndromic deafness 23 is usually identified by hearing tests and then confirmed with genetic tests. Early and accurate diagnosis can help you plan ahead with confidence. When possible, a genetic diagnosis of Autosomal recessive nonsyndromic deafness 23 guides care, supports communication planning, and informs family testing.
Hospitals use quick checks that measure the ear’s response to sound. If a baby does not pass, repeat testing and a full hearing evaluation are arranged.
Detailed tests (like ABR and OAE) map the type and degree of hearing loss. This profile helps determine whether the loss is likely sensorineural and if hearing aids or implants may help.
A multigene hearing loss panel can look for changes in genes linked to this condition. Finding disease-causing variants in both copies of the same gene confirms the diagnosis of Autosomal recessive nonsyndromic deafness 23.
A detailed family and health history can help identify patterns that suggest inherited hearing loss. This also clarifies who else in the family may benefit from testing.
Stages of Autosomal recessive nonsyndromic deafness 23
Autosomal recessive nonsyndromic deafness 23 does not have defined progression stages. This form of genetic hearing loss is usually present from birth or early childhood and varies between individuals and families, so it doesn’t follow a uniform, step-by-step decline. Early symptoms of Autosomal recessive nonsyndromic deafness 23 may include not startling at loud sounds, not turning to familiar voices, or delayed speech, and diagnosis typically relies on newborn hearing screening and specialized hearing tests with an audiologist. Different tests may be suggested to help confirm the cause and guide care, including genetic testing (often of the PCDH15 gene) and regular follow-up hearing checks over time.
Outlook and prognosis
Hearing in Autosomal recessive nonsyndromic deafness 23 can be stable for some people and more changeable for others, shaping school, work, and communication choices over time. Many people ask, “What does this mean for my future?”, and the short answer is that life expectancy is typical, because this condition affects hearing without involving other organs. Most children are identified early through newborn screening or early symptoms of Autosomal recessive nonsyndromic deafness 23, and timely access to hearing aids, cochlear implants, and language support helps set strong foundations for learning and social development.
The outlook is not the same for everyone, but early care can make a real difference in speech, education, and long‑term independence. Hearing levels in Autosomal recessive nonsyndromic deafness 23 may be present at birth or decline in childhood; some families notice steady hearing, while others see gradual changes that call for device adjustments. Importantly, this condition by itself is not linked to higher mortality, and most people enjoy a normal lifespan. When thinking about the future, it helps to plan for regular hearing checks, device maintenance, and school or workplace accommodations so communication stays smooth as needs evolve.
Understanding the prognosis can guide planning and help set realistic, hopeful goals. With ongoing care, many people maintain strong communication—whether through spoken language, sign language, or both—and participate fully in school, sports, and careers. Talk with your doctor about what your personal outlook might look like, including whether genetic results or your hearing pattern suggest stability or change over time. Support from friends and family can make day‑to‑day life easier, from practicing listening strategies in noisy places to making sure devices are charged and working well.
Long-term effects
Autosomal recessive nonsyndromic deafness 23 is a lifelong hearing condition that primarily affects how sound is detected and used for communication over time. Long-term effects vary widely, but most people have stable, bilateral hearing loss present from birth. The long-term effects of autosomal recessive nonsyndromic deafness 23 center on communication, learning environments, and social interaction rather than general health. Life expectancy is expected to be typical.
Hearing loss is usually present in both ears from birth and often ranges from severe to profound. For many, it remains stable over decades, though small changes can occur.
Spoken speech patterns and articulation may differ from hearing peers. Language development can follow a different timeline because access to sound is reduced.
Language-heavy tasks like reading aloud, following lectures, or group discussions may be harder without clear sound access. Written literacy can be strong, but classroom participation may depend on visual communication.
Group conversations and noisy settings can be tiring and hard to follow. Some may experience listening fatigue after sustained effort to track speech.
How is it to live with Autosomal recessive nonsyndromic deafness 23?
Autosomal recessive nonsyndromic deafness 23 usually means being born with hearing loss or developing it early, so daily life often centers on clear communication, accessible environments, and early support. Many find confidence through sign language, hearing technology such as hearing aids or cochlear implants when appropriate, and visual-first tools at school and work; fatigue from constant listening effort can be real, so pacing and quiet breaks help. Family, friends, and coworkers play a key role by learning preferred communication methods, reducing background noise, maintaining eye contact, and using captions—small changes that make conversations smooth and inclusive. With early intervention, community connection, and consistent access to communication, people with this form of deafness can thrive in education, careers, and relationships.
Treatment and drugs
Autosomal recessive nonsyndromic deafness 23 is managed by improving hearing and communication rather than changing the gene itself. Most people are offered hearing aids first; if hearing loss is severe or hearing aids don’t help enough, cochlear implants can provide access to sound for many children and adults. Early symptoms of Autosomal recessive nonsyndromic deafness 23 often lead families to start speech and language therapy, which supports communication development alongside school-based services. Alongside medical treatment, lifestyle choices play a role, including using assistive listening devices, captioning, and learning sign language or other visual communication if preferred. Genetic counseling can help explain inheritance, discuss testing for family members, and guide planning for future pregnancies.
Non-drug treatment
Living with hearing loss affects daily conversations, school, and work, but many tools can close those gaps. Early symptoms of Autosomal recessive nonsyndromic deafness 23 can be subtle in infancy, so early referral and fitting of hearing technology make a real difference. Non-drug treatments often lay the foundation for communication, learning, and social connection. Plans are tailored to severity and age, and usually blend devices, therapy, and family-focused supports.
These devices amplify speech and everyday sounds for mild to severe hearing loss. An audiologist custom-fits them and adjusts settings over time for comfort and clarity. Consistent daily use helps the brain make the most of amplified sound.
For severe to profound loss, a surgically placed device can send sound signals directly to the hearing nerve. Follow-up programming and listening therapy are essential to build understanding of speech. Many do best with both ears aided or implanted when appropriate.
Remote microphones, classroom FM/DM systems, and hearing loops bring the speaker’s voice closer and reduce background noise. These tools can improve listening in school, meetings, or restaurants. Many pair with hearing aids or implants.
Structured coaching builds listening and spoken language using the child’s hearing devices. Parents learn everyday strategies to turn routines into practice. Over time, this can sharpen attention to speech sounds.
Your genes may have an impact on how drugs work for you
Some medicines for hearing-related conditions or associated infections can be processed faster or slower depending on your genes, which can change how well they work and the chance of side effects. Genetic testing can sometimes guide safer dosing or alternative drug choices.
Pharmacological treatments
There’s no medicine that can reverse the inner‑ear changes in Autosomal recessive nonsyndromic deafness 23 (DFNB23), so drug therapy focuses on specific situations and protecting the hearing you have. Alongside drug therapy, hearing devices and speech-language therapy remain important. Medicines may be used for sudden new drops in hearing, middle‑ear infections, or to lower the risk of drug‑related hearing damage. Your care team will tailor choices based on your age, other health needs, and how DFNB23 affects daily communication.
There are currently no medications that restore hearing in DFNB23. Medicines are used for complications or protection rather than cure. Early symptoms of Autosomal recessive nonsyndromic deafness 23 often appear in infancy, so devices and therapy are the mainstays.
Prednisone by mouth or dexamethasone placed through the eardrum may be tried for sudden new hearing loss or inner‑ear inflammation. These medicines generally do not improve congenital genetic hearing loss like DFNB23.
If acute otitis media develops, antibiotics such as amoxicillin or amoxicillin‑clavulanate may be prescribed. Clearing the infection can reduce a temporary conductive block that further muffles hearing in DFNB23.
Some medicines can harm hearing, including aminoglycosides (gentamicin, tobramycin), chemotherapy such as cisplatin, and high‑dose loop diuretics like furosemide. Ask your doctor why a specific drug was recommended for you.
Genetic influences
This type of hearing loss is caused by inheriting two non-working copies of the same gene, one from each parent. When both parents carry the change, each child has a 25% chance to have Autosomal recessive nonsyndromic deafness 23, a 50% chance to be a carrier, and a 25% chance to inherit neither change. A “carrier” means you hold the gene change but may not show symptoms. In Autosomal recessive nonsyndromic deafness 23, the gene is called PCDH15, and it helps the tiny sound-sensing cells of the inner ear do their job. Changes in PCDH15 often cause hearing loss from birth, but the degree can differ between families and even between siblings. Genetic testing for Autosomal recessive nonsyndromic deafness 23 can identify the exact change, confirm the cause, and help tell this hearing-only condition apart from related disorders that also affect vision and balance.
Is Autosomal recessive nonsyndromic deafness 23 genetic?
Genetics are central in Autosomal recessive nonsyndromic deafness 23. It’s caused by variants in both copies of a specific gene, usually inherited from carrier parents. Different variants can influence age of onset, severity, and response to options like cochlear implants.
Pharmacogenetics—how genetics influence drug effects
For people with Autosomal recessive nonsyndromic deafness 23, the specific gene change can guide when to consider hearing aids versus cochlear implants, because the inner ear’s sound-sensing cells are mainly affected while the hearing nerve is usually intact. Genetic testing can sometimes identify how your body handles medicines that can harm hearing, such as certain aminoglycoside antibiotics, helping doctors choose safer options or add extra monitoring if those drugs are necessary. One well-recognized example is a specific mitochondrial gene change that greatly raises the risk of sudden, permanent hearing loss after aminoglycosides; if this is found, these drugs are usually avoided unless there’s no substitute. Knowing the exact cause of Autosomal recessive nonsyndromic deafness 23 can also set expectations: when the ear’s hair cells are the main issue, cochlear implants often provide clearer access to sound than hearing aids alone. Testing early—soon after early symptoms of Autosomal recessive nonsyndromic deafness 23 are noticed—can help plan timely implantation and reduce exposure to ototoxic medicines during hospital care. While genetics is only one factor, it can reduce trial and error by aligning treatment choices and medication safety with each person’s biology.
Interactions with other conditions
People living with Autosomal recessive nonsyndromic deafness 23 mainly face hearing challenges, but other health issues can add to or mask those difficulties. Ear infections, seasonal allergies, or a buildup of middle-ear fluid can temporarily drop hearing further, and certain medicines that are hard on the inner ear—like some antibiotics (aminoglycosides) or chemotherapy drugs (cisplatin)—may worsen any remaining hearing if not monitored. Certain diseases may “overlap,” meaning changes in the same gene can lead to a different condition; for example, other variants in the PCDH15 gene can cause Usher syndrome, which involves vision and balance problems, though people diagnosed with the nonsyndromic form typically do not develop eye disease. Noise exposure at work or concerts and age-related hearing loss can also stack on top of the inherited loss, making communication tougher than expected for someone’s age. In infants, early symptoms of Autosomal recessive nonsyndromic deafness 23 can be hard to tell apart from hearing loss due to congenital infections like cytomegalovirus (CMV), so timely hearing tests and, when appropriate, genetic testing help sort this out. If you use hearing aids or are considering a cochlear implant, let every clinician know about the diagnosis so they can choose ear-safe medications, coordinate vaccines when needed, and plan care that protects the hearing you have.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and communities once noticed patterns of children born with normal health but very limited hearing, especially in places where relatives married within the same village or extended family. Grandparents might recall a cousin who signed fluently, while siblings heard well. Before newborn hearing screening, many children with what we now call autosomal recessive nonsyndromic deafness 23 were first recognized when they didn’t startle to loud sounds or didn’t develop speech as expected.
First described in the medical literature as part of broader “hereditary deafness,” this form was initially grouped together with many others because no outward features distinguished one type from another. Early reports focused on when the hearing loss began, how severe it was, and whether balance or other senses were affected. Over time, clinicians noticed that some families had hearing loss alone—no differences in growth, learning, or facial features—which pointed to a nonsyndromic pattern.
From these first observations, researchers built detailed family trees to understand how the condition traveled across generations. They saw that hearing parents could have more than one child with significant, often congenital, hearing loss. This fit an autosomal recessive pattern: the condition appears when a child inherits two nonworking copies of the same gene, one from each parent. Mapping studies in the late 20th and early 21st centuries narrowed the search to specific regions of chromosomes linked to deafness in different families, each region labeled “DFNB” followed by a number.
Advances in genetics then allowed scientists to move from chromosome regions to the exact genes involved. When the gene behind autosomal recessive nonsyndromic deafness 23 was identified, it clarified why the hearing loss was isolated to the inner ear. The gene’s job relates to the tiny structures that turn sound vibrations into electrical signals for the brain. When this gene works poorly, those structures can’t send clear signals, leading to the early symptoms of autosomal recessive nonsyndromic deafness 23, often noticed in infancy.
With each decade, genetic testing improved, making it possible to confirm the diagnosis without invasive tests. This helped separate autosomal recessive nonsyndromic deafness 23 from other genetic hearing conditions that might have different ages of onset or additional health features. It also explained why two parents with normal hearing could have more than one child with similar hearing loss.
Not every early description was complete, yet together they built the foundation of today’s knowledge. Modern care now blends newborn screening, timely hearing support such as hearing aids or cochlear implants when appropriate, and family counseling. Looking back helps explain why names and categories changed over time—and why a precise genetic answer can guide care while reminding families that hearing differences have been part of human experience for generations.